OpenAlex
PricingAboutJobs
Log inGet started
Work

Ceftazidime/Avibactam, Meropenem/Vaborbactam, or Both? Clinical and Formulary Considerations

HTML

Year: 2018
Type: review
Source: Clinical Infectious Diseases
DOI: 10.1093/cid/ciy576
Authors: Jason M Pogue, Robert A Bonomo, Keith S Kaye
Institutions: Wayne State University, Detroit Medical Center, Sinai Grace Hospital, Louis Stokes Cleveland VA Medical Center, Case Western Reserve University, University of Michigan, Michigan Medicine
Language: English

Topic: Antibiotic Resistance in Bacteria
Subfield: Microbiology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: ceftazidime-avibactam, meropenem-vaborbactam, carbapenem-resistant Enterobacteriaceae, carbapenem resistance mechanisms, colistin, in vitro antibacterial activity, resistance selection, hospital formulary, antibiotic stewardship, invasive infections
SDG: Good health and well-being

Open Access status: closed

Funders: Merck, Achaogen, Shionogi, Allergan
OpenAlex ID: W2883732289
FWCI: 2.096
Cites: 31
Cited by: 173
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms